Breast augmentation surgery is expensive with a long recovery time - but now, there's an alternative that's non-surgical and ...

Q4 2024 Results Conference Call February 4, 2025 8:30 AM ETCompany ParticipantsMiri Segal - CEO, MS-IRMoshe Mizrahy - ...

a randomized phase Ib-II MORPHEUS-Liver study showed. At the clinical cutoff date, the 41 patients assigned to treatment with tiragolumab had a confirmed objective response rate of 43% compared ...

Morpheus is committed to ensuring that builders are also recognized for their hard work, not just agents or compute providers The platform employs a distribution ...

The U.S. Food and Drug Administration has approved Axsome Therapeutics' Symbravo (meloxicam and rizatriptan) for the acute ...

The lab of The Wistar Institute's Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant ...

Jeffrey Hatrix, the former frontman for the popular metal band Mushroomhead, has given an update on his cancer battle just weeks after first making the revelation. In a post recently shared by his ...

ONCE upon a time, “work” meant a boring 9 to 5. Today, in my world, it means Botox, filler, polynucleotides, Profhilo, ...

The full-year 2024 revenue was $394.8 million, a 20% decrease from the previous year. Despite these setbacks, the company continues to lead in the aesthetic market, supported by its extensive ...